Opicapone Film-coated Tablets 25mg (Ongentys® / オンジェンティス錠25mg)

JPY ¥36,400

Japanese Peripheral COMT Inhibitor (Opicapone 25mg). Oral tablet for improvement of wearing-off phenomenon in Parkinson’s disease in combination with levodopa. 30 tablets [10 tablets (PTP) x 3]. Mfd. by Ono Pharmaceutical Co., Ltd., Japan.

Bulk deal
Quantity Discount Discounted price
5 - 9 8% JPY ¥33,488
10 - 19 12% JPY ¥32,032
20 + 18% JPY ¥29,848
SKU: ONG-25-TAB Category:

Description

Product Overview / 商品概要

Ongentys Tablets 25mg (オンジェンティス錠25mg)
Generic: Opicapone / オピカポン
Therapeutic Category: Peripheral COMT Inhibitor / 末梢COMT阻害剤
Manufactured by: Ono Pharmaceutical Co., Ltd. / 小野薬品工業株式会社

Composition & Specification / 組成・規格

Active Ingredient: Opicapone 25mg per tablet / 1錠中 オピカポン 25mg
Additives: Lactose hydrate, Partially pregelatinized starch, Sodium starch glycolate, Magnesium stearate, Hypromellose, Titanium oxide, Macrogol 6000, Ferric oxide / 乳糖水和物、部分アルファー化デンプン、デンプングリコール酸ナトリウム、ステアリン酸マグネシウム、ヒプロメロース、酸化チタン、マクロゴール6000、三二酸化鉄
Appearance: Film-coated tablet, light red, major axis approx. 11.6mm, minor axis approx. 5.1mm, thickness approx. 3.6mm, weight approx. 205mg
外観: フィルムコーティング錠、淡赤色、長径約11.6mm、短径約5.1mm、厚さ約3.6mm、質量約205mg

Indications / 効能効果

EN: Improvement of motor fluctuations (wearing-off phenomenon) in Parkinson’s disease in combination with levodopa/carbidopa or levodopa/benserazide hydrochloride
JA: レボドパ・カルビドパ又はレボドパ・ベンセラジド塩酸塩との併用によるパーキンソン病における症状の日内変動(wearing-off現象)の改善

Dosage and Administration / 用法用量

EN: To be used in combination with levodopa/carbidopa or levodopa/benserazide hydrochloride. The usual adult dose is 25mg of opicapone once daily, administered orally at least 1 hour before or after levodopa/carbidopa or levodopa/benserazide hydrochloride dosing and at least 1 hour before or after meals.
JA: 本剤は、レボドパ・カルビドパ又はレボドパ・ベンセラジド塩酸塩と併用する。通常、成人にはオピカポンとして25mgを1日1回、レボドパ・カルビドパ又はレボドパ・ベンセラジド塩酸塩の投与前後及び食事の前後1時間以上あけて経口投与する。

Contraindications / 禁忌

EN: Patients with a history of hypersensitivity to any component of this product / Patients with pheochromocytoma, paraganglioma, or other catecholamine-secreting tumors / Patients with a history of malignant syndrome or non-traumatic rhabdomyolysis / Patients with severe hepatic impairment (Child-Pugh Class C)
JA: 本剤の成分に対し過敏症の既往歴のある患者/褐色細胞腫又はパラガングリオーマ若しくはその他のカテコールアミン分泌腫瘍のある患者/悪性症候群又は非外傷性横紋筋融解症の既往歴のある患者/重度肝機能障害(Child-Pugh分類C)のある患者

Regulatory Information / 規制情報

Approval No.: 30200AMX00487000
Sales Started: August 2020 / 2020年8月
Classification Code: 871169
Storage: Store at room temperature / 室温保存
Shelf Life: 4 years / 4年

Packaging / 包装

Main Package (for sale): 30 tablets [10 tablets (PTP) x 3] / 30錠[10錠(PTP)×3]
Other Available Packages (by special order): 30 tablets [10 tablets (PTP) x 3] / 100 tablets [10 tablets (PTP) x 10] / 100 tablets [bottle, bulk]

Full product insert (添付文書) is attached as a downloadable PDF. For detailed precautions, drug interactions, and safety information, please refer to the official package insert.

Additional information

重さ 0.15 kg

Reviews

There are no reviews yet.

Be the first to review “Opicapone Film-coated Tablets 25mg (Ongentys® / オンジェンティス錠25mg)”

メールアドレスが公開されることはありません。 が付いている欄は必須項目です

Export from Japan — Opicapone Film-coated Tablets 25mg (Ongentys®

🏭 Supply & Origin

  • Country of Origin: Japan
  • Regulatory Standard: PMDA (Japan) / GMP Compliant
  • Pharmacopoeia: Japanese Pharmacopoeia (JP)
  • Supplier: Mate Co., Ltd. — Licensed Pharmaceutical Wholesaler (License No. B14309, Osaka)
  • Supply Capacity: Full-line sourcing through Japan's regulated distribution channels

🚚 Shipping & Trade Terms

  • Incoterms: FOB Kansai International Airport (KIX)
  • Shipping: Air freight via B/L or AWB
  • Payment: 100% T/T in advance
  • Lead Time: 2-4 weeks after payment confirmation
  • Available Regions: EU, LATAM, APAC, Middle East, Africa

Request a Quotation

For pricing, MOQ, and regulatory documentation, contact our export team:

Email: kurimoto@mate-osaka.co.jp
Tel: +81-72-665-5736

All exports are conducted through proper regulatory procedures including customs clearance, B/L or AWB documentation, and T/T advance payment. We do not engage in hand-carry, cash transactions, or sales to unlicensed parties.